Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses S Elisaf

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
European Journal of Cardiovascular Nursing|March 15, 2011
The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in GreeceDimitrios Tziallas, Catherine Kastanioti, Michael S Kostapanos, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 17, 2010
Review: Antiplatelet drugs: what comes next?Anastazia A Kei, Matilda Florentin, Dimitri P Mikhailidis, et al.
Metabolism: Clinical and Experimental|September 19, 2006
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Sofia G Tsouli, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Vascular Pharmacology|June 3, 2009
Visfatin/PBEF and atherosclerosis-related diseasesTheodosios D Filippatos, Harpal S Randeva, Christos S Derdemezis, et al.
Southern Medical Journal|January 24, 2003
Acid-base and electrolyte disturbances in patients with hypercalcemiaHaralampos J Milionis, Evangelos Rizos, George Liamis, et al.
Archives of Medical Science : AMS|March 22, 2013
The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F2a levelsChristos V Rizos, Evangelos N Liberopoulos, Constantinos C Tellis, et al.
Stroke|June 4, 2005
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjectsHaralampos J Milionis, Evangelos Rizos, John Goudevenos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 20, 2014
The effect of rosuvastatin on low-density lipoprotein subfractions in patients with impaired fasting glucoseChristos V Rizos, Michael S Kostapanos, Evangelos C Rizos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceSofia G Tsouli, Evagelos N Liberopoulos, Dimitrios N Kiortsis, et al.
Current Medical Research and Opinion|April 2, 2005
A review of the lipid-related effects of fluvastatinEvagelos N Liberopoulos, Stella S Daskalopoulou, Dimitri P Mikhailidis, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
European Journal of Cardiovascular Nursing|March 15, 2011
The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in GreeceDimitrios Tziallas, Catherine Kastanioti, Michael S Kostapanos, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 17, 2010
Review: Antiplatelet drugs: what comes next?Anastazia A Kei, Matilda Florentin, Dimitri P Mikhailidis, et al.
Metabolism: Clinical and Experimental|September 19, 2006
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Sofia G Tsouli, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Vascular Pharmacology|June 3, 2009
Visfatin/PBEF and atherosclerosis-related diseasesTheodosios D Filippatos, Harpal S Randeva, Christos S Derdemezis, et al.
Southern Medical Journal|January 24, 2003
Acid-base and electrolyte disturbances in patients with hypercalcemiaHaralampos J Milionis, Evangelos Rizos, George Liamis, et al.
Archives of Medical Science : AMS|March 22, 2013
The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F2a levelsChristos V Rizos, Evangelos N Liberopoulos, Constantinos C Tellis, et al.
Stroke|June 4, 2005
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjectsHaralampos J Milionis, Evangelos Rizos, John Goudevenos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 20, 2014
The effect of rosuvastatin on low-density lipoprotein subfractions in patients with impaired fasting glucoseChristos V Rizos, Michael S Kostapanos, Evangelos C Rizos, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 17, 2006
Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidenceSofia G Tsouli, Evagelos N Liberopoulos, Dimitrios N Kiortsis, et al.
Current Medical Research and Opinion|April 2, 2005
A review of the lipid-related effects of fluvastatinEvagelos N Liberopoulos, Stella S Daskalopoulou, Dimitri P Mikhailidis, et al.
Pageof 20